company background image
PURE logo

PURE Bioscience OTCPK:PURE Stock Report

Last Price

US$0.087

Market Cap

US$9.7m

7D

-19.6%

1Y

-26.4%

Updated

29 Nov, 2024

Data

Company Financials

PURE Stock Overview

Develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. More details

PURE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

PURE Bioscience, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PURE Bioscience
Historical stock prices
Current Share PriceUS$0.087
52 Week HighUS$0.17
52 Week LowUS$0.059
Beta0.037
11 Month Change-6.66%
3 Month Change37.94%
1 Year Change-26.36%
33 Year Change-71.97%
5 Year Change-70.03%
Change since IPO-99.83%

Recent News & Updates

Recent updates

Shareholder Returns

PUREUS Household ProductsUS Market
7D-19.6%1.4%0.5%
1Y-26.4%16.6%30.7%

Return vs Industry: PURE underperformed the US Household Products industry which returned 17.9% over the past year.

Return vs Market: PURE underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is PURE's price volatile compared to industry and market?
PURE volatility
PURE Average Weekly Movement29.0%
Household Products Industry Average Movement3.1%
Market Average Movement6.3%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: PURE's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PURE's weekly volatility has increased from 24% to 29% over the past year.

About the Company

FoundedEmployeesCEOWebsite
199212Robert Bartlettwww.purebio.com

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. Its technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products.

PURE Bioscience, Inc. Fundamentals Summary

How do PURE Bioscience's earnings and revenue compare to its market cap?
PURE fundamental statistics
Market capUS$9.72m
Earnings (TTM)-US$3.35m
Revenue (TTM)US$1.96m

5.0x

P/S Ratio

-2.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PURE income statement (TTM)
RevenueUS$1.96m
Cost of RevenueUS$811.00k
Gross ProfitUS$1.15m
Other ExpensesUS$4.50m
Earnings-US$3.35m

Last Reported Earnings

Jul 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.03
Gross Margin58.69%
Net Profit Margin-170.66%
Debt/Equity Ratio-103.0%

How did PURE perform over the long term?

See historical performance and comparison